Ocugen (OCGN) Non-Current Deferred Tax Liability (2014)

Ocugen's (OCGN) quarterly Non-Current Deferred Tax Liability came in at $651000.0 in Q4 2014.

Analysis

Ocugen (OCGN) Non-Current Deferred Tax Liability (2014) Analysis & Trends

Ocugen (OCGN) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $651000.0 in Q4 2014.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $651000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $651000.0 (changed N/A YoY) and the FY2014 annual result came in at $651000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability steadied at $651000.0 in Q4 2014.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $651000.0 in Q4 2014 to a low of $651000.0 in Q4 2014.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
10	Ocugen	458.91 Mn	358.81 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	651,000.00